Literature DB >> 14603511

Comparison of the four anhydrous polymorphs of carbamazepine and the crystal structure of form I.

Adam L Grzesiak1, Meidong Lang, Kibum Kim, Adam J Matzger.   

Abstract

For decades, carbamazepine (CBZ) has served as a model compound for groups engaged in the study of crystal polymorphism. Despite considerable effort, crystal structures for only three of its four anhydrous forms have previously been determined. Herein, we report the first single crystal X-ray structure of the high temperature modification of CBZ (form I). Form I crystallizes in a triclinic cell (P-1) having four inequivalent molecules with the following lattice parameters: a = 5.1705(6), b = 20.574(2), c = 22.245(2) A, alpha = 84.12(4), beta = 88.01(4), and gamma = 85.19(4) degrees. Furthermore, we compare the physical properties of the four anhydrous polymorphs of CBZ, including the first comprehensive characterization of form IV. Substantial differences are seen among these forms by powder X-ray diffraction, infrared spectroscopy, thermomicroscopy, and differential scanning calorimetry. These data are correlated to their respective crystal structures for the first time. We have found that all polymorphs possess identical strong hydrogen bonding patterns, similar molecular conformations, and stabilities that are within 0.7 kcal/mol of each other. Copyright 2003 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 92:2260-2271, 2003

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14603511     DOI: 10.1002/jps.10455

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  41 in total

1.  Parallel thermal analysis technology using an infrared camera for high-throughput evaluation of active pharmaceutical ingredients: a case study of melting point determination.

Authors:  Kohsaku Kawakami
Journal:  AAPS PharmSciTech       Date:  2010-07-31       Impact factor: 3.246

2.  Improving the chemical stability of amorphous solid dispersion with cocrystal technique by hot melt extrusion.

Authors:  Xu Liu; Ming Lu; Zhefei Guo; Lin Huang; Xin Feng; Chuanbin Wu
Journal:  Pharm Res       Date:  2011-10-19       Impact factor: 4.200

3.  Dehydration kinetics and crystal water dynamics of carbamazepine dihydrate.

Authors:  K Kachrimanis; U J Griesser
Journal:  Pharm Res       Date:  2012-04       Impact factor: 4.200

4.  Data requirements for the reliable use of atomic pair distribution functions in amorphous pharmaceutical fingerprinting.

Authors:  Timur Dykhne; Ryan Taylor; Alastair Florence; Simon J L Billinge
Journal:  Pharm Res       Date:  2011-01-08       Impact factor: 4.200

5.  Stability-enhanced hot-melt extruded amorphous solid dispersions via combinations of Soluplus® and HPMCAS-HF.

Authors:  Saad M Alshahrani; Wenli Lu; Jun-Bom Park; Joseph T Morott; Bader B Alsulays; Soumyajit Majumdar; Nigel Langley; Karl Kolter; Andreas Gryczke; Michael A Repka
Journal:  AAPS PharmSciTech       Date:  2015-01-08       Impact factor: 3.246

6.  Investigating Cocrystallization of Carbamazepine with Structurally Compatible Coformers: New Cocrystal and Eutectic Phases with Enhanced Dissolution.

Authors:  Indumathi Sathisaran; Sameer Vishvanath Dalvi
Journal:  AAPS PharmSciTech       Date:  2021-01-06       Impact factor: 3.246

7.  Polymorphism in phenobarbital: discovery of a new polymorph and crystal structure of elusive form V.

Authors:  Saikat Roy; N Rajesh Goud; Adam J Matzger
Journal:  Chem Commun (Camb)       Date:  2016-03-21       Impact factor: 6.222

8.  Crystal polymorphism in a carbamazepine derivative: oxcarbazepine.

Authors:  Katie M Lutker; Adam J Matzger
Journal:  J Pharm Sci       Date:  2010-02       Impact factor: 3.534

9.  Porous starch: a novel carrier for solubility enhancement of carbamazepine.

Authors:  Meer Tarique Ali; Ritesh Fule; Ajay Sav; Purnima Amin
Journal:  AAPS PharmSciTech       Date:  2013-05-29       Impact factor: 3.246

10.  Self-built supercritical CO2 anti-solvent unit design, construction and operation using carbamazepine.

Authors:  Dan Meng; James Falconer; Karen Krauel-Goellner; John J J J Chen; Mohammed Farid; Raid G Alany
Journal:  AAPS PharmSciTech       Date:  2008-08-09       Impact factor: 3.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.